Trade-Ideas: Cormedix (CRMD) Is Today's Weak On High Relative Volume Stock

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Cormedix ( CRMD) as a weak on high relative volume candidate. In addition to specific proprietary factors, Trade-Ideas identified Cormedix as such a stock due to the following factors:

  • CRMD has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $4.4 million.
  • CRMD has traded 102,531 shares today.
  • CRMD is trading at 2.24 times the normal volume for the stock at this time of day.
  • CRMD is trading at a new low 7.01% below yesterday's close.

'Weak on High Relative Volume' stocks are worth watching because major volume moves tend to indicate underlying activity such as material stock news, analyst downgrades, insider selling, selling from 'superinvestors,' or that hedge funds and traders are piling out of a stock ahead of a catalyst. Regardless of the impetus behind the price and volume action, when a stock moves with strength and volume it can indicate the start of a new trend on which early investors can capitalize (or avoid losses by trimming weak positions). In the event of a well-timed trading opportunity, combining technical indicators with fundamental trends and a disciplined trading methodology should help you take the first steps towards investment success.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in CRMD with the Ticky from Trade-Ideas. See the FREE profile for CRMD NOW at Trade-Ideas

If you liked this article you might like

4 Stocks Under $10 to Trade for Big Breakouts

3 Stocks Under $10 Making Big Moves

Cormedix (CRMD): Today's Weak On High Volume Stock

Biotech Stock Mailbag: Unstoppable Heron, Aerie Disclosure Fail, Gene Therapy, Hate Mail!

CorMedix (CRMD) Stock Gains After Receiving Positive FDA Feedback for Neutrolin